Posted by Michael Wonder on 23 Oct 2022
PHARMAC publishes agenda for November 2022 PTAC meeting
21 October 2022 - The agenda for the November 2022 PTAC meeting is now available.
The PTAC will consider application for the following technologies:
- Liraglutide - obesity
- Certolizumab pegol - rheumatoid arthritis
- Fluticasone furoate with vilanterol trifenatate - asthma
- Pertuzumab and trastuzumab - breast cancer
- Cardioplegia solution - cardiac surgery
- Eribulin mesylate - breast cancer
- Physostigmine bromide - anticholinergic agent toxicity
- Clodronate sodium - osteoradionecrosis
